Truist Financial Corp Purchases 102 Shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Truist Financial Corp lifted its position in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating) by 3.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,388 shares of the company’s stock after acquiring an additional 102 shares during the quarter. Truist Financial Corp’s holdings in iShares US Pharmaceuticals ETF were worth $575,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in IHE. First Manhattan Co. acquired a new stake in shares of iShares US Pharmaceuticals ETF during the first quarter worth $46,000. Venture Visionary Partners LLC acquired a new stake in shares of iShares US Pharmaceuticals ETF during the second quarter worth $53,000. Hallmark Capital Management Inc. acquired a new stake in shares of iShares US Pharmaceuticals ETF during the second quarter worth $57,000. Blair William & Co. IL acquired a new stake in shares of iShares US Pharmaceuticals ETF during the first quarter worth $58,000. Finally, Magnus Financial Group LLC acquired a new stake in shares of iShares US Pharmaceuticals ETF during the second quarter worth $204,000.

iShares US Pharmaceuticals ETF Stock Down 0.2 %

Shares of iShares US Pharmaceuticals ETF stock opened at $185.58 on Monday. iShares US Pharmaceuticals ETF has a 12 month low of $166.99 and a 12 month high of $202.77. The business has a fifty day simple moving average of $185.51 and a 200 day simple moving average of $182.82.

About iShares US Pharmaceuticals ETF

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

See Also

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares US Pharmaceuticals ETF (NYSEARCA:IHEGet Rating).

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.